Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: A study of 426 patients from a single centre

Postgraduate Medical Journal

Volumn 81, Issue 961, 2005, Pages 723-727

  Chen, M ^a   Yu, F ^a   Zhang, Y ^a   Zhao, M H ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CHILD; CHINESE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; EYE DISEASE; FATIGUE; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; NOSE DISEASE; PATHOLOGY; RASH; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS; ASIAN; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; PROGNOSIS; TIME; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY DISEASES; LUNG DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; TIME FACTORS; VASCULITIS;

EID: 27844599620     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.034215     Document Type: Article

References (25)

1. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990;33:1088-93.
3. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR project for ANCA assay standardization. Kidney Int 1998;53:743-53.
4. Watts RA, Carruthers DM, Scott DG. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1995;25:28-34.
5. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
6. Stone JH. Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial, Arthritis Rheum 2003;48:2299-309.
7. Watts RA, Scott DG. Epidemiology of the vasculitides. Curr Opin Rheumatol 2003;15:11-16.
8. Zhao MH, Wang HY, Zhang YK. The renal involvement of primary vasculitis: clinical and pathological analysis of 5 cases. Chin J Intern Med 1993;32:40-3.
9. Xin G, Zhao MH, Wang HY. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin Diagn Lab Immunol 2004;11:559-62.
10. Zhao MH, Lockwood CM. A comprehensive method to purifiy three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability- increasing protein from human neutrophil granule acid extract. J Immunol Meth 1996;197:121-30.
11. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, et al. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill consensus conference definitions. Arthritis Rheum 2003;15:388-93.
12. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-84.
13. Wang Y, Zhao MH, Yu J, et al. The clinical and pathological characters of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated small vasculitis. Exp Gerontol 2004;39:1401-5.
14. Yu F, Zhao MH, Huang JP, et al. Clinical and pathological features of anti-neutrophil antibody associated systemic vasculitis in children. Zhonghua Er Ke Za Zhi 2003;41:831-4.
15. Kamesh L, Harper L, Savage COS. ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-60.
16. Watts RA, Lane SE, Scott DG, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001;60:1156-7.
17. Watts RA, Scott DGI. Epidemiology of the vasculitides. Curr Opin Rheumatol 2003;15:11-16.
18. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register. Rheumatology 2002;41:540-9.
19. Li H, He B, Zhu Y, et al. Diagnosis and treatment of primary small vessel vasculitis with involvement of lungs. Chin J Tuberc Respir Dis 1999;22:347-50.
20. Bajema IM, Hagen EC, Hermans J, et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999;56:1751-8.
21. Franssen C, Gans R, Kallenberg C, et al. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 1998;244:209-16.
22. Franssen CF, Stegeman CA, Kallenberg CG, et al. Antiproteinase 3 and antimyeloperoxidase-associated vasculitis. Kidney Int 2000;57:2195-206.
23. Hauer HA, Bajema IM, van Houwelingen, et al. Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups. Kidney Int 2002;61:80-9.
24. Tse WY, Cockwell P, Savage COS. Assessment of disease activity in systemic vasculitis. Postgrad Med J 1998;74:1-6.
25. Vassilopoulos D, Niles JL, Villa Forte A, et al. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Rheum 2003;49:151-5.